Literature DB >> 6098455

The first exon of region E1a genes of adenoviruses 5 and 12 encodes a separate functional protein domain.

A G Jochemsen, J L Bos, A J van der Eb.   

Abstract

The transforming E1 regions of human adenoviruses Ad5 and Ad12 differ from each other in the frequency by which they can transform primary baby rat kidney cells, and in their ability to modulate expression of class I major histocompatibility (MHC) genes. We have investigated whether these two properties, which are determined by region E1a, can be assigned to one of the two protein segments encoded by the E1a exons. To that end, we have constructed chimaeric E1a regions, in which the 5' E1a exon of Ad5 was linked to the 3' E1a exon of Ad12, and vice versa. It was found that, although there is only a limited degree of homology between Ad5 and Ad12 E1a (approximately 40% at the protein level), the hybrid E1a products are functional in transformation. Furthermore, both the frequency of transformation and the modulation of class I MHC gene expression appeared to be determined by the first E1a exon. These results indicate that the first E1a exon encodes a separate functional domain in the E1a proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098455      PMCID: PMC557790          DOI: 10.1002/j.1460-2075.1984.tb02233.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  24 in total

1.  Characterization of tumor antigens in cells transformed by fragments of adenovirus type 5 DNA.

Authors:  P I Schrier; P J Van Den Elsen; J J Hertoghs; A J Van Der Eb
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

2.  Proteins and messenger RNAs of the transforming region of wild-type and mutant adenoviruses.

Authors:  H Esche; M B Mathews; J B Lewis
Journal:  J Mol Biol       Date:  1980-09-25       Impact factor: 5.469

3.  Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site.

Authors:  C Montell; E F Fisher; M H Caruthers; A J Berk
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

4.  Transformation-deficient adenovirus mutant defective in expression of region 1A but not region 1B.

Authors:  D Solnick; M A Anderson
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

5.  Assay of transforming activity of tumor virus DNA.

Authors:  A J van der Eb; F L Graham
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets.

Authors:  J L Bos; L J Polder; R Bernards; P I Schrier; P J van den Elsen; A J van der Eb; H van Ormondt
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

7.  Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

8.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

Authors:  A Houweling; P J van den Elsen; A J van der Eb
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

9.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

10.  Defective transforming capacity of adenovirus type 5 host-range mutants.

Authors:  F L Graham; T Harrison; J Williams
Journal:  Virology       Date:  1978-05-01       Impact factor: 3.616

View more
  19 in total

Review 1.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

2.  Adenovirus E1A gene autorepression: revertants of an E1A promoter mutation encode altered E1A proteins.

Authors:  P L Larsen; C Tibbetts
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells.

Authors:  H Haddada; A M Lewis; J A Sogn; J E Coligan; J L Cook; T A Walker; A S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 4.  The structure and functions of the adenovirus early region 1 proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

5.  Similar effects of adenovirus E1A and glucocorticoid hormones on the expression of the metalloprotease stromelysin.

Authors:  R Offringa; A M Smits; A Houweling; J L Bos; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

6.  Mapping of functional domains in adenovirus E1A proteins.

Authors:  B Krippl; B Ferguson; N Jones; M Rosenberg; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300.

Authors:  H G Wang; P Yaciuk; R P Ricciardi; M Green; K Yokoyama; E Moran
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene.

Authors:  A G Jochemsen; R Bernards; H J van Kranen; A Houweling; J L Bos; A J van der Eb
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

9.  Recombinant human adenoviruses containing hybrid adenovirus type 5 (Ad5)/Ad12 E1A genes: characterization of hybrid E1A proteins and analysis of transforming activity and host range.

Authors:  T Jelinek; F L Graham
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  A first exon-encoded domain of E1A sufficient for posttranslational modification, nuclear-localization, and induction of adenovirus E3 promoter expression in Xenopus oocytes.

Authors:  J D Richter; P Young; N C Jones; B Krippl; M Rosenberg; B Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.